MyFinsight
Home
Blog
About
Back
Income Statement
Lexeo Therapeutics, Inc. (LXEO)
Lexeo Therapeutics, Inc. (LXEO)
source: myfinsight.com
Comprehensive loss
-$26,023K
Net loss
-$25,867K
(0.90%↑ Y/Y)
Total other
comprehensive gain (loss)
-$156K
Interest income
$2,194K
(73.03%↑ Y/Y)
Loss from operations
before income taxes
-$25,867K
(0.90%↑ Y/Y)
Net unrealized gain
(loss) on investments...
-$156K
Total other income and
expense
$2,153K
(-53.04%↓ Y/Y)
(amortization of premium)
accretion of discount on...
-$21K
Interest expense
$14K
(-44.00%↓ Y/Y)
Other expense, net
-$6K
(57.14%↑ Y/Y)
Operating loss
-$28,020K
(8.69%↑ Y/Y)
Total operating
expenses
$28,020K
(-8.69%↓ Y/Y)
Research and development
$19,027K
(29.25%↑ Y/Y)
General and
administrative
$8,993K
(-43.68%↓ Y/Y)
Back